
Genetic Technologies Limited GENE
Geschäftsbericht 2022
hinzugefügt 30.08.2022
Genetic Technologies Limited ROE 2011-2026 | GENE
ROE Jährlich Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.4 | -32.87 | -44.99 | -362.78 | -115.96 | -79.44 | -71.18 | -46.47 | -554.04 | -161.48 | -36.71 | 13.35 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.35 | -554.04 | -128.0 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | - | - | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 29.8 | -3.87 % | $ 321 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.13 | -3.54 % | $ 1.44 M | ||
|
Castle Biosciences
CSTL
|
4.0 | - | - | $ 914 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Danaher Corporation
DHR
|
7.87 | $ 219.93 | 0.09 % | $ 161 B | ||
|
Celcuity
CELC
|
-96.68 | $ 104.25 | 0.08 % | $ 4.11 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
26.18 | - | - | $ 26.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 209.75 | 2.09 % | $ 23.3 B | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-72.81 | $ 19.51 | -5.18 % | $ 1.05 B | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.07 | 1.37 % | $ 314 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
Exact Sciences Corporation
EXAS
|
-35.99 | $ 103.42 | - | $ 19.2 B | ||
|
Interpace Biosciences
IDXG
|
-302.3 | $ 1.82 | - | $ 7.98 M | ||
|
Lantheus Holdings
LNTH
|
28.72 | $ 67.04 | - | $ 4.64 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 23.02 | - | $ 696 M | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | - | -0.62 % | $ 28.7 B | ||
|
Guardant Health
GH
|
312.48 | $ 106.6 | 1.65 % | $ 13.1 B | ||
|
NeoGenomics
NEO
|
-8.72 | $ 11.47 | - | $ 1.45 B | ||
|
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B | ||
|
Natera
NTRA
|
-77.62 | - | -0.5 % | $ 20.7 B | ||
|
OPKO Health
OPK
|
1.03 | $ 1.25 | 2.05 % | $ 868 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
0.64 | - | -9.16 % | $ 8.49 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 32.03 | -2.72 % | $ 20 B | ||
|
IDEXX Laboratories
IDXX
|
55.65 | - | - | $ 53.5 B | ||
|
Illumina
ILMN
|
-51.54 | $ 117.01 | -1.95 % | $ 18.6 B | ||
|
IQVIA Holdings
IQV
|
22.63 | $ 176.27 | - | $ 32 B | ||
|
Biodesix
BDSX
|
-205.65 | - | - | $ 1.33 B | ||
|
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 289.4 | 1.75 % | $ 24.3 B | ||
|
ENDRA Life Sciences
NDRA
|
-449.46 | $ 3.56 | -4.56 % | $ 1.91 M | ||
|
ICON Public Limited Company
ICLR
|
8.31 | - | - | $ 11 B | ||
|
Quidel Corporation
QDEL
|
60.8 | - | -3.13 % | $ 1.19 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.23 | - | $ 5.12 M | ||
|
Bioventus
BVS
|
-90.0 | $ 8.04 | - | $ 504 M |